Cancer Prevention

  • Hans-Jörg Senn
  • Ursula Kapp
Conference proceedings

DOI: 10.1007/978-3-540-37696-5

Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 174)

Table of contents (22 papers)

  1. Front Matter
    Pages I-XIV
  2. Genetic Risk Profiles and Biomarkers in Cancer Prevention

    1. Front Matter
      Pages 1-1
    2. Helmut Bartsch, Heike Dally, Odilia Popanda, Angela Risch, Peter Schmezer
      Pages 19-36
    3. Friedrich Marks, Gerhard Fürstenberger, Karin Müller-Decker
      Pages 37-47
  3. Inflammation, Infection, and Cancer Prevention

  4. Prevention of Female and Male Genital Cancers

    1. Front Matter
      Pages 79-79
    2. Robert C. Bast Jr., Molly Brewer, Changping Zou, Mary A. Hernandez, Mary Daley, Robert Ozols et al.
      Pages 91-100
    3. Hans-Peter Schmid, Daniel S. Engeler, Karl Pummer, Bernd J. Schmitz-Dräger
      Pages 101-107
  5. Prevention of Breast Cancer

    1. Front Matter
      Pages 109-109
    2. Jose Russo, Gabriela Balogh, Daniel Mailo, Patricia A. Russo, Rebecca Heulings, Irma H. Russo
      Pages 131-150
    3. Anthony Howell, Robert B. Clarke, Gareth Evans, Nigel Bundred, Jack Cuzick, Richard Santen et al.
      Pages 151-167
  6. Prevention of Colorectal Cancers

    1. Front Matter
      Pages 169-169

About these proceedings

Introduction

This volume contains the main proceedings of the fourth international conference on "Cancer Prevention 2006," which was held during February 16–18, 2006, in St. Gallen, Switzerland. Written by international experts in the field, the book comprises a comprehensive update on the most recent developments in the upsurging fields of molecular biology and cancer genetics and their interactions with clinical epidemiology and cancer prevention at various levels: genetic/biologic predisposition and definition of high-risk groups; preclinical models and tumor prevention; prospects of surrogate endpoints and biomarkers; progress in imaging and detection of neoplastic precursor lesions; problems with Cox-2 inhibitors in tumor chemoprevention; primary and secondary prevention of gynecological, breast, gastrointestinal and genitourinary cancers. In addition, the future prospects of cancer chemoprevention are discussed.

Keywords

Carcinom Genetic/biologic predisposition High-risk group cancer chemoprevention genetics molecular biology neoplastic precursor lesions surrogate endpoints tumor chemoprevention

Editors and affiliations

  • Hans-Jörg Senn
    • 1
  • Ursula Kapp
    • 1
  1. 1.Tumor-Zentrum ZeTuP St. Gallen/Chur (Tumordiagnostik, Behandlung + Prävention)St. GallenSchweiz

Bibliographic information

  • Copyright Information Springer-Verlag Berlin Heidelberg 2007
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Medicine
  • Print ISBN 978-3-540-37695-8
  • Online ISBN 978-3-540-37696-5
  • Series Print ISSN 0080-0015